Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Merger & Restructuring

Every merger & restructuring announcement on NSE and BSE that our alert engine sent, newest first.

18:12 IST NSE
Merger & RestructuringAther Energy Ltd ATHERENERG

Ather Energy Merger & Restructuring Worth ₹2.02 Cr

Ather Energy Limited is incorporating a wholly-owned subsidiary, Ather Energy Hong Kong Limited, for Rs.2.02 Crore. The entity will support supply chain procurement in the APAC region.

Value
₹2.02 Cr
14:57 IST BSE
Merger & RestructuringThyrocare Technologies Ltd THYROCARE

Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr

Thyrocare's board approved sale of 100% in Nueclear Healthcare to Trovera for ~₹141.40 Crore. The move exits radiology to refocus on core pathology business.

Value
₹141.4 Cr
Execution
On or before November 30, 2026
14:50 IST BSE
Merger & RestructuringDilip Buildcon Ltd DBL

Dilip Buildcon Merger & Restructuring Worth ₹6,829 Cr

DBL sells its 1,363 MW solar portfolio stake to Alpha Alternatives at an enterprise value of ₹6,829 Cr. The deal advances its asset-light, asset-recycling strategy.

Value
₹6,829 Cr
solar capacity
1363.0 MW
19:11 IST BSE
Merger & RestructuringArvaya Healthcare Ltd BIJHANS

Arvaya Healthcare Merger & Restructuring Worth ₹0.8 Cr

Arvaya Healthcare has incorporated a wholly-owned subsidiary, Arvaya Insurance Broking Private Limited, for an investment of ₹0.80 Crore. This entity will provide insurance broking services.

Value
₹0.80 Cr
17:56 IST BSE
Merger & RestructuringIndoco Remedies Ltd INDOCO

Indoco Remedies Merger & Restructuring Worth ₹0.01 Cr

Indoco Remedies will incorporate a new wholly owned subsidiary, Warren Lifesciences Private Limited, for the pharmaceutical business with an initial capital of Rs. 1 Lakh.

Value
₹0.01 Cr
12:54 IST BSE
Merger & RestructuringTCM Ltd TCMLMTD

TCM Merger & Restructuring Worth ₹25 Cr

TCM Ltd signed an MOU to form a JV SPV for a Kalamassery villa project. Investor Suhas Nandan will inject Rs 25 Crore loan capital.

Value
₹25.00 Cr
Execution
3 years (loan return period; max 4 years from disbursement)